News

National Institutes of Health criticised for not preventing conflicts of interest

BMJ 2004; 329 doi: 10.1136/bmj.329.7456.10-b (Published 1 July 2004)
Cite this as: BMJ 2004;329:10.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Janice Hopkins Tanne
  1. New York

    The US National Institutes of Health (NIH) has been criticised by members of Congress for letting employees accept lucrative consultancy assignments from drug and biotechnology companies.

    On 22 June the director of the NIH, Dr Elias Zerhouni, told the House Energy and Commerce Oversight and Investigations Subcommittee, “In retrospect, there was not a sufficient safeguard against the perception of conflict of interest.” He said the NIH would tighten rules about employees' consultancy work.

    The NIH's troubles began on 7 December 2003. …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular